Posts by Sandra Ansanay-Alex
Diverssity, MoleSense and Performance Mouthguard each receive Tech Seed Loans
Three innovations have been recognized by the Foundation for Innovation and Technology (FIT), with three start-ups receiving Tech Seed loans. First, Diverssity received CHF 50,000 for its therapeutic, multisensory game “My Magic Room,” designed for neurodiverse adolescents with autism spectrum disorder. Next is MoleSense, which will be able to develop its wearable skin sensor for…
Read MoreVenture Leaders Biotech 2026: 10 innovative biotech startups selected for the Boston roadshow
Ten startups, 4 of them from the Swiss Health Valley, have been selected for the 2026 Venture Leaders Biotech programme, which will take them to Boston from May 31st to June 5th as part of the Swiss National Startup Team. During their roadshow, the entrepreneurs will connect with international investors and industry leaders, acquiring expertise…
Read MoreDexterous Endoscopes receives CHF 150,000 from Venture Kick
The EPFL spin-off Dexterous Endoscopes has obtained CHF 150,000 from Venture Kick to develop endoscopes with variable stiffness that provide surgeons with greater control and advanced tissue dissection capabilities. The medtech startup aims to enable new minimally invasive procedures in hard-to-reach areas within the sinuses and larynx, with future applications in other organs. Millions of…
Read MoreThe Swiss Data Science Center Opens Headquarters at Biopôle in Lausanne
The Swiss Data Science Center (SDSC) inaugurating its headquarters at the Biopôle campus in Lausanne, as part of a strategic partnership with the State of Vaud. This is the first time that SDSC has had a space independent of its partner institutions – EPFL, ETH Zurich, and PSI – thereby strengthening its presence in French-speaking…
Read MoreGreen Lab Symposium
The Green Lab Symposium is taking place on 11 June 2026 at Life Science Centre PULSE – Cheseaux-sur-Lausanne Green Lab is an initiative of the association ‘Green Building Switzerland’. This non-profit organisation acts as a competent catalyst to strengthen the competitiveness of Swiss cutting-edge research through innovative and sustainable laboratories. The Green Lab Symposium is…
Read MoreSeprify Raised CHF 12.25 million in Series A Funding
Seprify, a spin-off from the University of Fribourg and the University of Cambridge, now based at the Marly Innovation Centre (MIC), is a bio-materials company developing high-performance cellulose-based ingredients for industrial applications, announced the transition of its cellulose platform from pilot validation into procurement-ready industrial supply. This enables manufacturers to move from trials into repeatable…
Read MoreGiannina Iannotti, from HUG NeuroCentre, Received the BCV 2025 Sustainability Award
Giannina Iannotti, coordinator of the HUG NeuroCentre, received the BCV 2025 Sustainability Award, given to the HEC Lausanne Executive MBA strategic consulting project with the greatest impact in terms of sustainability. An academic project with real-world benefits The Optimising HUG Outpatient Care for Mild and Moderate Traumatic Brain Injury project proposes a sustainable model rooted…
Read MorePolares Medical Raises $50 million in Series C Funding
The funding was supported by DC Global Ventures, Lumination Capital, existing investors and a new strategic investor, to help advance MRace‘s US expansion following strong clinical results. Polares Medical SA (‘Polares’), a Swiss Health Valley clinical-stage structural heart company developing the MRace mitral valve replacement system for mitral valve regurgitation (MR), announced the closing of…
Read MoreTherapy Dogs Bring Comfort to Children with Cancer at CHUV
Two therapy dogs have recently joined the daily life of children hospitalized in the Pediatric Hematology-Oncology Unit at the Children’s Hospital of Lausanne University Hospital (CHUV). This pilot initiative — the first of its kind in Switzerland within a pediatric oncology unit — represents an important step forward in integrating complementary therapies to support the…
Read MoreSwiss MedTech Startup HeroSupport Secures CE Mark for VENUS SHELL™
On International Women’s Day, HeroSupport, a University of Geneva spinoff, announced that its first medical device, VENUS SHELL™, has received CE Mark certification and is now authorised for marketing across the European Union and Switzerland. The CE mark confirms compliance with all applicable EU health, safety, and environmental standards. It enables deployment in hospitals and…
Read More